Expansion Opportunity Sharp is rapidly expanding its autoinjector and pen assembly capacity in the US and EU, including Belgium and Pennsylvania, with multi-million investments and new lines becoming operational by early 2027. This presents an opportunity to offer complementary packaging, sterile fill/finish, and cold-chain logistics services to support growing injectable programs and expand clinical to commercial supply for rare diseases and orphan drugs.

European Capacity Buildout Significant investments in European packaging facilities, including Belgium and broader EU capacity for two to 100 devices per minute and temperature-controlled warehousing, indicate strong injectables demand. Sales teams can position enhanced European manufacturing, packaging automation, and cold-chain solutions to multinational biotech clients seeking EU-based supply for clinical and commercial programs.

Leadership & Digital Transformation With a new Chief Technology Officer and a focus on innovation, scalability, and IT modernization, Sharp signals a modernization agenda. This creates opportunities to propose integrated digital manufacturing platforms, data-driven quality systems, and seamless IT-enabled collaborations for sponsors seeking digital improvements in scale-up, regulatory readiness, and real-time supply chain visibility.

Global Network & Proximity A footprint across the US, UK, Belgium, Netherlands, plus 30+ clinical depots, enables near-market support and risk diversification for clients. This network can be leveraged to offer multi-regional packaging, cold chain storage, and decentralized distribution solutions tailored to sponsors aiming for global launches with consistent quality and supply reliability.

Financial Scale & Demand Revenue tier and substantial funding indicate strong financial capacity to invest in additional CDMO services. Sales opportunities exist to package complementary services such as clinical trial manufacturing, sterile fill/finish, logistics, and post-approval commercial packaging for injectable therapies, enabling long-term, multi-year partnerships.